Atmaram Khanolkar, a talented inventor based in Coventry, RI (US), has made significant contributions to the field of cannabinoid research. With a remarkable portfolio of 10 patents to his name, Khanolkar has been at the forefront of developing novel polycyclic cannabinoid analogs and bicyclic cannabinoids that target the cannabinoid CB2 receptor sites.

Latest Patents:

1. Peripheral cannabinoid receptor (CB2) selective ligands: Khanolkar's groundbreaking work involves the development of novel polycyclic cannabinoid analogs with high affinities for the cannabinoid CB2 receptor sites.

2. Bicyclic cannabinoids: He has also pioneered the creation of bicyclic cannabinoids and their methods of preparation and use, which have shown promising therapeutic effects in treating various physiological conditions.

Career Highlights:

Atmaram Khanolkar is currently associated with the University of Connecticut, where he continues to drive innovation in the field of cannabinoid research. His dedication to exploring the therapeutic potential of cannabinoids has garnered recognition within the scientific community and beyond.

Collaborations:

Khanolkar has collaborated with esteemed colleagues such as Alexandros Makriyannis and Dai Lu, further expanding the scope of his research and fostering a culture of innovation and exploration in his field.

Conclusion:

Inventor Atmaram Khanolkar's groundbreaking work in cannabinoid research stands as a testament to his passion for driving scientific advancements. Through his patents and collaborations, Khanolkar continues to push the boundaries of innovation, contributing valuable insights to the medical and pharmaceutical industries.

If you need further information or have any specific questions, feel free to reach out.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com